FIND Sequencing-Based Tuberculosis Drug Resistance Testing Gaining Momentum Premium The WHO and FIND are supporting NGS-based testing in low-resource settings, while a resistance testing program at New York State's Wadsworth Center has matured. Cepheid Debuts 10-Color Molecular Detection Technology With New Tuberculosis Test Premium The firm launched a CE-IVD marked test for extremely drug-resistant TB and expects to incorporate the multiplexing technology in other assays. UK Government Invests $28M in FIND to Support SARS-CoV-2 Test Development FIND will use the funding to support the development of rapid tests, especially in low- and middle-income countries. Q&A: FIND's Cassandra Kelly-Cirino Discusses COVID-19 Diagnostics Pipelines The Foundation for Innovative New Diagnostics is tracking commercial coronavirus diagnostics development project, with the goal of guiding procurement. FIND, WHO Collaborate on Novel Coronavirus MDx Evaluation The two organizations are collaborating to perform a standardized evaluation of currently available molecular diagnostic tests to assess test performance. Nov 7, 2019 SpeeDx, QuantuMDx Collaborate with FIND on POC Molecular Diagnostics for STIs Jul 5, 2019 FIND, Unitaid Sign $14.5M Deal to Evaluate NGS-Based Diagnosis of Drug-Resistant TB Apr 30, 2019 Malaria Test from Eiken Chemical Detects Less-Diagnosed Species Premium Sep 19, 2018 India's MolBio Brings Tuberculosis MDx to Point of Care With Help From FIND Premium Aug 8, 2018 Genedrive, FIND Partner on HCV Assay Evaluation Study Aug 30, 2017 Study Highlights Cepheid's Next-Generation TB, Rifampicin Resistance Assay Premium Dec 3, 2015 Cepheid, FIND to Evaluate Point-of-Care MDx System, TB Test Oct 8, 2015 Consortium Seeks to Provide Centralized Access to Global TB Data for Research, Dx Development Premium Oct 7, 2015 Paul G. Allen Ebola Program Awards $6.9M for Ebola Diagnostics Jul 1, 2015 Field Evaluation of Rapid Ebola Immunoassay Reveals Limitations of PCR-Based Testing Premium Apr 16, 2015 Cepheid Qualitative HIV-1 Test Receives CE Mark Mar 19, 2015 Study IDs TB Strains in Swaziland with Drug Resistance Mutations Not Detected by Cepheid Xpert Test Premium Dec 29, 2014 Cepheid's HIV MDx Assay Gains CE-IVD Mark Oct 28, 2014 FIND Collaborates with Multiple Firms on MDx Tests for TB May 23, 2013 Studies Indicate Effectiveness of New LAMP-based Malaria Test in Modern Labs, Endemic Countries Premium Apr 18, 2013 Lumora-FIND Malaria Screening Test May be Tip of Iceberg in MDx Development Partnership Premium Apr 17, 2013 Lumora, FIND Partner to Develop High-throughput Malaria Assay Dec 15, 2011 National U of Singapore, FIND Team on TB Marker Project Sep 15, 2011 FIND, Eiken Begin Clinical Field Trials for LAMP-Based African Sleeping Sickness Dx Premium Feb 3, 2011 In Wake of Q4 Profit, Cepheid Says FIND Will Provide $5M for HIV Viral Load Test Premium Load More Breaking News People in the News: New Appointments at Sema4, Strata Oncology, Bionano Genomics, More Co-Diagnostics Gets CE Mark for Saliva-Based Molecular SARS-CoV-2 Test Yourgene Health Awarded £232K Contract to Supply Oncology Genotyping Testing Kits to NHS Wales Qiagen to Distribute JADBio Life Science Analytics Platform BC Platforms Forms Data Management Alliance With Nonprofit CureDuchenne 23andMe Stock Soars 22 Percent on Closing of Merger With VG Acquisition Corp The Scan Billions for Antivirals The US is putting $3.2 billion toward a program to develop antivirals to treat COVID-19 in its early stages, the Wall Street Journal reports. NFT of the Web Tim Berners-Lee, who developed the World Wide Web, is auctioning its original source code as a non-fungible token, Reuters reports. 23andMe on the Nasdaq 23andMe's shares rose more than 20 percent following its merger with a special purpose acquisition company, as GenomeWeb has reported. Science Papers Present GWAS of Brain Structure, System for Controlled Gene Transfer In Science this week: genome-wide association study ties variants to white matter stricture in the brain, and more.